ANAB logo

AnaptysBio (ANAB) Shareholders Equity

Annual Shareholders Equity

$88.10 M
-$174.00 M-66.39%

December 31, 2023


Summary


Performance

ANAB Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANABbalance sheetmetrics:

Quarterly Shareholders Equity

$84.37 M
+$74.49 M+754.00%

September 1, 2024


Summary


Performance

ANAB Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANABbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ANAB Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-66.4%+76.6%
3 y3 years-77.8%-78.0%
5 y5 years-81.9%-80.0%

ANAB Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-75.3%at low-76.3%+754.0%
5 y5-year-78.3%at low-79.2%+754.0%
alltimeall time-81.9%>+9999.0%-83.1%+1341.4%

AnaptysBio Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$84.37 M(+754.0%)
Jun 2024
-
$9.88 M(-79.3%)
Mar 2024
-
$47.78 M(-45.8%)
Dec 2023
$88.10 M(-66.4%)
$88.10 M(-26.8%)
Sep 2023
-
$120.38 M(-18.9%)
Jun 2023
-
$148.45 M(-22.3%)
Mar 2023
-
$191.09 M(-27.1%)
Dec 2022
$262.10 M(-26.5%)
$262.10 M(-5.6%)
Sep 2022
-
$277.62 M(-8.8%)
Jun 2022
-
$304.31 M(-8.0%)
Mar 2022
-
$330.75 M(-7.2%)
Dec 2021
$356.43 M(-10.2%)
$356.43 M(-7.1%)
Sep 2021
-
$383.61 M(-0.6%)
Jun 2021
-
$385.73 M(+1.0%)
Mar 2021
-
$381.94 M(-3.7%)
Dec 2020
$396.73 M(-2.0%)
$396.73 M(+10.1%)
Sep 2020
-
$360.24 M(-5.6%)
Jun 2020
-
$381.44 M(-4.8%)
Mar 2020
-
$400.56 M(-1.1%)
Dec 2019
$405.01 M
$405.01 M(-3.8%)
DateAnnualQuarterly
Sep 2019
-
$420.89 M(-6.1%)
Jun 2019
-
$448.42 M(-4.2%)
Mar 2019
-
$468.15 M(-3.7%)
Dec 2018
$486.37 M(+58.1%)
$486.37 M(-2.7%)
Sep 2018
-
$499.68 M(+75.3%)
Jun 2018
-
$284.98 M(-3.2%)
Mar 2018
-
$294.53 M(-4.2%)
Dec 2017
$307.58 M(+683.3%)
$307.58 M(+203.5%)
Sep 2017
-
$101.36 M(-7.2%)
Jun 2017
-
$109.17 M(-0.9%)
Mar 2017
-
$110.11 M(+180.4%)
Dec 2016
$39.27 M(-7.2%)
$39.27 M(-12.3%)
Sep 2016
-
$44.76 M(+0.8%)
Jun 2016
-
$44.40 M(+6.3%)
Mar 2016
-
$41.78 M(-1.3%)
Dec 2015
$42.34 M(+606.4%)
$42.34 M(-7.1%)
Sep 2015
-
$45.58 M(+678.8%)
Jun 2015
-
$5.85 M(-2.3%)
Dec 2014
$5.99 M(+4033.1%)
$5.99 M
Dec 2013
$145.00 K
-

FAQ

  • What is AnaptysBio annual stockholders equity?
  • What is the all time high annual shareholders equity for AnaptysBio?
  • What is AnaptysBio annual shareholders equity year-on-year change?
  • What is AnaptysBio quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AnaptysBio?
  • What is AnaptysBio quarterly shareholders equity year-on-year change?

What is AnaptysBio annual stockholders equity?

The current annual shareholders equity of ANAB is $88.10 M

What is the all time high annual shareholders equity for AnaptysBio?

AnaptysBio all-time high annual stockholders equity is $486.37 M

What is AnaptysBio annual shareholders equity year-on-year change?

Over the past year, ANAB annual stockholders equity has changed by -$174.00 M (-66.39%)

What is AnaptysBio quarterly stockholders equity?

The current quarterly shareholders equity of ANAB is $84.37 M

What is the all time high quarterly shareholders equity for AnaptysBio?

AnaptysBio all-time high quarterly stockholders equity is $499.68 M

What is AnaptysBio quarterly shareholders equity year-on-year change?

Over the past year, ANAB quarterly stockholders equity has changed by +$36.59 M (+76.58%)